Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol acetate for weight loss prevention in head and neck cancer
NCT02980653Phase 2Unknown
- Sponsor
- TTY Biopharm Company Limited
- Start
- May 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of megestrol, sponsored by TTY Biopharm Company Limited. Primary endpoint: Critical body weight loss at 12 weeks. Status: unknown.
02
Drugs
megestrol
Beyond the preview
Go deeper on NCT02980653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980653.